Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Patients who have an ischemic stroke in the morning, or onset of their active period, are not only at a greater risk for poor outcome based on the hyperfibrinolytic morning state, but additionally, response to thrombolytic intervention is less efficacious during the morning time points
Adv Exp Med Biol 1999;466:327-37 83 -Carpenter KH ea
And then you've just gone through COVID, so everyone's confused
Remember that decisions about GLP-1 therapy should be made collaboratively, considering your individual circumstances, preferences, and the latest available evidence
If a patient reports worsening reflux symptoms after starting Ozempic, the appropriate first step is to manage the GLP-1-related GI effects (slower titration, dietary modification, smaller meals) rather than to escalate PPI therapy or assume a drug interaction
